Does Serum 25 Hydroxy Vitamin D Level Predict Disease Activity in Ulcerative Colitis Patients? Publisher Pubmed



Dolatshahi S¹ ; Pishgar E¹ ; Jamali R^{1, 2} Show Affiliations
Source: Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine Published:2016

Abstract

Background/Aim: There are controversial results regarding the relationship of serum 25 hydroxy vitamin D [25(OH)D] and ulcerative colitis (UC) activity. To address this issue, the current study was designed to evaluate the correlation of serum 25(OH)D level and disease activity in patients with UC. Method: All consecutively selected UC outpatients referred to a gastroenterology clinic were enrolled in 2014. UC was diagnosed based on clinical, colonoscopic and histologic findings by a gastroenterologist. The exclusion criteria consisted of the factors that might influence plasma 25(OH)D concentration including inadequate exposure or intake, reduced absorption and abnormal metabolism. Disease activity was assessed by ‘Truelove and Witts’ classification’. Results: Fifty UC patients with mean age of 36.98 (± 11.81) years were evaluated. Mean serum 25(OH)D concentrations were significantly higher in ‘mild disease activity’ group (27.06 ± 6.56 ng/ml) than ‘moderate disease activity’ group (11.14 ± 4.03 ng/ml). Lower serum 25(OH)D concentration was associated with an increased likelihood of exhibiting moderate disease activity [β = 0.37, 95% confidence interval (CI): 0.15-0.94, p value = 0.04]. Conclusion: Lower serum 25(OH)D level might be associated with higher disease activity in UC patients with mild-to-moderate activity. © Acta Clinica Belgica 2016.